Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
33 studies found for:    " April 07, 2010":" May 07, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
22 Completed Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Etravirine
23 Completed Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
Conditions: Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.;   Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,;   HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
Intervention:
24 Completed HIV Risk Reduction in Subutex Injectors in Tbilisi
Condition: HIV
Interventions: Drug: methadone;   Drug: buprenorphine-naloxone (Suboxone) for 12 weeks
25 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
26 Completed Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy
Condition: HIV
Intervention: Procedure: Lumbar puncture
27 Unknown  The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho
Conditions: AIDS/HIV PROBLEM;   Sexually Transmitted Diseases
Intervention: Behavioral: Financial incentive through lotteries
28 Unknown  Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
Conditions: Opioid-Related Disorders;   Buprenorphine;   HIV;   Cognition;   HIV Infections
Intervention:
29 Active, not recruiting TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV
Condition: HIV-1 Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir
30 Unknown  Injecting Drug Use Community Intervention Trial
Conditions: HIV;   Hepatitis C;   Syphilis;   HSV-2;   HIV Infections
Intervention: Behavioral: Intervention
31 Completed Risk Reduction Intervention for Vulnerable Young Adult Males
Conditions: Sex;   Substance Use;   HIV
Intervention: Behavioral: HIV prevention intervention randomized control trial
32 Completed Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Conditions: Coronary Heart Disease;   Heart Failure;   HIV;   AIDS;   Metabolic Syndrome
Intervention: Other: Comprehensive non invasive cardiovascular examination
33 Completed Mid-life Women: Preventing Unintended Pregnancy and STIs
Condition: Reproductive Health
Interventions: Behavioral: Women's Reproductive Health;   Behavioral: Online sexual health content

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page   
Study has passed its completion date and status has not been verified in more than two years.